LISA JOHNS: Open Payments
NPI 1982964664 · GAHANNA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,312 in 70 payments from 18 companies in 2025. Trend: 2023 $2,099 · 2024 $734 · 2025 $1,312
Food & beverage: $1,312
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $288 |
| PFIZER INC. | 17 | $192 |
| AstraZeneca Pharmaceuticals LP | 8 | $178 |
| ABBVIE INC. | 13 | $138 |
| Madrigal Pharmaceuticals | 1 | $120 |
| Gilead Sciences, Inc. | 4 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| SANOFI-AVENTIS U.S. LLC | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
Products named: Wegovy, NURTEC ODT, REZDIFFRA, FARXIGA, Ozempic, AIRSUPRA, VRAYLAR, CAPLYTA.
Industry payments across OH — which companies pay providers there.
